GRADE summary of evidence for thrombolysis followed by AC vs AC alone in patients with massive PE
| No. of studies . | Study design . | No. of patients (%) . | Effect . | Certainty . | Importance . | ||
|---|---|---|---|---|---|---|---|
| Thrombolysis followed by AC . | AC alone . | Relative (95% CI) . | Absolute (95% CI) . | ||||
| Mortality (assessed with: all-cause mortality) | |||||||
| 219,20 | Nonrandomized studies | 6/10 (50.0) | 8/16 (50.0) | RR, 0.88 (0.42-1.85) | 60 fewer per 1000 (290 fewer to 425 more) | ⊕○○○ Very low∗,†  | Critical | 
| Thrombus recurrence | |||||||
| 119 | Nonrandomized studies | 3/7 (42.9) | 3/15 (20.0) | RR, 2.14 (0.57-8.09) | 228 more per 1000 (86 fewer to 1000 more) | ⊕○○○ Very low∗,†  | Critical | 
| Bleeding (assessed with: unspecified bleed [intracranial/extracranial]) | |||||||
| 120 | Nonrandomized studies | 1/7 (14.3) | 0/1 (0.0) | Not estimable | Not estimable | ⊕○○○ Very low∗,†  | Critical | 
| No. of studies . | Study design . | No. of patients (%) . | Effect . | Certainty . | Importance . | ||
|---|---|---|---|---|---|---|---|
| Thrombolysis followed by AC . | AC alone . | Relative (95% CI) . | Absolute (95% CI) . | ||||
| Mortality (assessed with: all-cause mortality) | |||||||
| 219,20 | Nonrandomized studies | 6/10 (50.0) | 8/16 (50.0) | RR, 0.88 (0.42-1.85) | 60 fewer per 1000 (290 fewer to 425 more) | ⊕○○○ Very low∗,†  | Critical | 
| Thrombus recurrence | |||||||
| 119 | Nonrandomized studies | 3/7 (42.9) | 3/15 (20.0) | RR, 2.14 (0.57-8.09) | 228 more per 1000 (86 fewer to 1000 more) | ⊕○○○ Very low∗,†  | Critical | 
| Bleeding (assessed with: unspecified bleed [intracranial/extracranial]) | |||||||
| 120 | Nonrandomized studies | 1/7 (14.3) | 0/1 (0.0) | Not estimable | Not estimable | ⊕○○○ Very low∗,†  | Critical |